These data correlate well with previous observations in follicular thyroid carcinoma [38], glioma [13], non-small cell lung cancer [14], and endometrial cancer [15], again supporting the emerging role of ENO1 as a promising target for cancer treatment. This evidence concerns the gene ENO1 and non-small cell lung carcinoma.